Alzheimer's disease: a mini-review for the clinician

被引:11
|
作者
Madnani, Rishi S. S. [1 ]
机构
[1] Bates Coll, Lewiston, ME 04240 USA
来源
FRONTIERS IN NEUROLOGY | 2023年 / 14卷
关键词
neurodegeneration; medicine; pathophysiology; history; Alzheimer's disease; diagnosis; AMYLOID-BETA-PROTEIN; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RECOMMENDATIONS; INSULIN; TAU; PHOSPHORYLATION; OLIGOMERS; DEMENTIA;
D O I
10.3389/fneur.2023.1178588
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alzheimer's disease (AD), the most common form of dementia, is a striking example of the connection between neurophysiological abnormalities and higher-order cognitive deficiencies. Since its initial description in 1906, research into the pathophysiology and etiology of AD has led to the illumination of an incredibly complex set of genetic and molecular mechanisms for the disease's progression, characterized by much more than the neuropathological hallmarks of beta-amyloid (A & beta;) plaques and neurofibrillary tangles (NFTs). In this review, findings relating the neurodegeneration present in AD to its clinical presentation and treatment are summarized, with an emphasis on the interconnectedness of disease pathophysiology. Further, diagnostic guidelines are provided based on the National Institute on Aging-Alzheimer's Association (NIA-AA) workgroup's clinical recommendations. Through the dissemination of detailed but digestible open access resources such as this one, we can move towards an increase in the equity and accessibility of education for the modern clinician.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Biochemical Changes Evidenced in Alzheimer's Disease: A Mini-Review
    Scotti, Luciana
    Bezerra Mendonca Junior, Francisco Jaime
    da Silva, Marcelo Sobral
    Pitta, Ivan R.
    Scotti, Marcus Tullius
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2014, 11 (02) : 240 - 248
  • [2] The cognitive dysfunction of claustrum on Alzheimer's disease: A mini-review
    Chen, Chun-Yan
    Yang, Guang-Yi
    Tu, Hai-Xia
    Weng, Xu-Chu
    Hu, Chun
    Geng, Hong-Yan
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [3] Mini-review: Amyloid degradation toxicity hypothesis of Alzheimer's disease
    Zaretsky, Dmitry V.
    Zaretskaia, Maria V.
    [J]. NEUROSCIENCE LETTERS, 2021, 756
  • [4] Longitudinal Inflammation, Cognitive Decline, and Alzheimer's Disease: A Mini-Review
    Bettcher, B. M.
    Kramer, J. H.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (04) : 464 - 469
  • [5] Blood-based biomarkers in Alzheimer’s disease: a mini-review
    Sanjana P. Padala
    Paul A. Newhouse
    [J]. Metabolic Brain Disease, 2023, 38 : 185 - 193
  • [6] Mini-review: The suspected non-Alzheimer's disease pathophysiology
    Rizzi, Liara
    Balthazar, Marcio L. F.
    [J]. NEUROSCIENCE LETTERS, 2021, 764
  • [7] Blood-based biomarkers in Alzheimer's disease: a mini-review
    Padala, Sanjana P.
    Newhouse, Paul A.
    [J]. METABOLIC BRAIN DISEASE, 2023, 38 (01) : 185 - 193
  • [8] Metacognition and Perspective-Taking in Alzheimer's Disease: A Mini-Review
    Bertrand, Elodie
    Landeira-Fernandez, Jesus
    Mograbi, Daniel C.
    [J]. FRONTIERS IN PSYCHOLOGY, 2016, 7
  • [9] Type 3 diabetes is sporadic Alzheimer's disease: Mini-review
    de la Monte, Suzanne M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (12) : 1954 - 1960
  • [10] Mini-review - The importance of inflammatory mechanisms in Alzheimer disease
    McGeer, EG
    McGeer, PL
    [J]. EXPERIMENTAL GERONTOLOGY, 1998, 33 (05) : 371 - 378